EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hippocampal and neocortical BRAF mutant non‐expansive lesions in focal epilepsies

Julie Lerond, Bertrand Mathon iD, Mélina Scopin, Lucia Nichelli, Justine Guégan, Céline Bertholle, Brigitte Izac, Muriel Andrieu, Thomas Gareau, Florian Donneger, Badreddine Mohand Oumoussa, Franck Letourneur und 8 weitere

Neuropathology and Applied Neurobiology · 2023

DOI: 10.1111/nan.12937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, 2023. Verfasst von Julie Lerond und 19 weiteren Autor:innen. Beteiligte Einrichtung: Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Neocortex, Epilepsies, Partial, Epilepsy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Assistance Publique-Hôpitaux de Paris, Sorbonne Université, SiRIC CURAMUS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Mesial Temporal Lobe Epilepsy‐associated Hippocampal Sclerosis (MTLE‐HS) is a syndrome associated with various aetiologies. We previously identified CD34‐positive extravascular stellate cells (CD34+ cells) possibly related to BRAF V600E oncogenic variant in a subset of MTLE‐HS. We aimed to identify the BRAF V600E oncogenic variants and characterise the CD34+ cells.

Methods

We analysed BRAF V600E oncogenic variant by digital droplet Polymerase Chain Reaction in 53 MTLE‐HS samples (25 with CD34+ cells) and nine non‐expansive neocortical lesions resected during epilepsy surgery (five with CD34+ cells). Ex vivo multi‐electrode array recording, immunolabelling, methylation microarray and single nuclei RNAseq were performed on BRAF wildtype MTLE‐HS and BRAF V600E mutant non‐expansive lesion of hippocampus and/or neocortex.

Results

We identified a BRAF V600E oncogenic variant in five MTLE‐HS samples with CD34+ cells (19%) and in five neocortical samples with CD34+ cells (100%). Single nuclei RNAseq of resected samples revealed two unique clusters of abnormal cells (including CD34+ cells) associated with senescence and oligodendrocyte development in both hippocampal and neocortical BRAF V600E mutant samples. The co‐expression of the oncogene‐induced senescence marker p16 INK4A and the outer subventricular zone radial glia progenitor marker HOPX in CD34+ cells was confirmed by multiplex immunostaining. Pseudotime analysis showed that abnormal cells share a common lineage from progenitors to myelinating oligodendrocytes. Epilepsy surgery led to seizure freedom in eight of the 10 patients with BRAF mutant lesions.

Interpretation

BRAF V600E underlies a subset of MTLE‐HS and epileptogenic non‐expansive neocortical focal lesions. Detection of the oncogenic variant may help diagnosis and open perspectives for targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, Temporal LobeNeocortexEpilepsies, PartialEpilepsyHumansProto-Oncogene Proteins B-rafHippocampusSclerosisMagnetic Resonance Imaging

Stichwörter der Autor:innen

BRAFCD34HOPXepilepsyhippocampal sclerosismethylationsenescencesomatic mosaicism

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, Paris, France.
  • AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Department of Neurosurgery, Sorbonne Université, Paris, France.
  • Institut du Fer à Moulin, Inserm, Sorbonne Université, Paris, France.
  • AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Department of Neuroradiology, Sorbonne Université, Paris, France.
  • Institut du Cerveau-Paris Brain Institute-ICM-Data Analysis Core platform, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Sorbonne Université, Paris, France.
  • CNRS, INSERM, Institut Cochin, Université Paris Cité, Paris, France.

ORCID-Profile: Bertrand Mathon, Franck Bielle

Förderung

  • Assistance Publique-Hôpitaux de Paris
  • Sorbonne Université
  • SiRIC CURAMUS
  • DMU Neuroscience of AP-HP, Sorbonne Université
  • AmourAmourAmour
  • French National Cancer Institute, the French Ministry of Solidarity and Health and Inserm INCA-DGOS-Inserm_12560
  • Fondation pour la Recherche Medicale
  • Assistance Publique - Hôpitaux de Paris

Zitieren

APA

Lerond, J., Mathon, B., Scopin, M., Nichelli, L., Guégan, J., Bertholle, C., Izac, B., Andrieu, M., Gareau, T., Donneger, F., Mohand Oumoussa, B., Letourneur, F., Tran, S., Bertrand, M., Le Roux, I., Touat, M., Dupont, S., Poncer, J. C., Navarro, V., & Bielle, F. (2023). Hippocampal and neocortical BRAF mutant non‐expansive lesions in focal epilepsies. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12937

Vancouver

Lerond J, Mathon B, Scopin M, Nichelli L, Guégan J, Bertholle C, et al. Hippocampal and neocortical BRAF mutant non‐expansive lesions in focal epilepsies. Neuropathology and Applied Neurobiology. 2023. doi:10.1111/nan.12937

BibTeX
@article{Lerond2023,
  author = {Lerond, Julie and Mathon, Bertrand and Scopin, Mélina and Nichelli, Lucia and Guégan, Justine and Bertholle, Céline and Izac, Brigitte and Andrieu, Muriel and Gareau, Thomas and Donneger, Florian and Mohand Oumoussa, Badreddine and Letourneur, Franck and Tran, Suzanne and Bertrand, Mathilde and Le Roux, Isabelle and Touat, Mehdi and Dupont, Sophie and Poncer, Jean Christophe and Navarro, Vincent and Bielle, Franck},
  title = {Hippocampal and neocortical BRAF mutant non‐expansive lesions in focal epilepsies},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2023},
  doi = {10.1111/nan.12937}
}
Kostenlos starten →